...drug. The FDA encourages patients to talk with their health care provider or compounder about how to measure and administer the intended dose of compounded semaglutide. Many of the patients...
...clinical trials, as this case was an uncontrolled case study with a very small sample size. However, the potential of studies like this is encouraging the FDA to facilitate access to convalescent...
...counterfeit products may still be available for purchase. Drug analysis of the seized products is still underway. The needles from these samples are also counterfeit. Accordingly, the sterility of the...
...can begin. In reality, the timing of specialized diagnostic testing can be a complex decision that includes individual patient considerations and multiple stakeholders. Sometimes, speed matters: The ability for the...
Workers’ comp continues to grow more complex as the scope of care expands to a greater, more holistic view of patient wellness. Health concerns outside of a claim can significantly...
...Pulling insights from a Healthesystems 2020 research study specifically designed to understand more about the workers’ comp claims journey, pain points and opportunities to improve these pain points through digital...
...Compensation Research Institute (WCRI) examined 575,000 claims across 27 states, which represented 37-72% of workers’ comp claims in each state, and found that opioid prescribing dropped significantly in comp claims. In...
...seizures and nerve pain, conditions which are common in workers’ compensation. It is therefore possible that injured workers could be taking gabapentinoids along with opioids, leading to potential breathing difficulties....
...for Priority Review the New Drug Application (NDA) for MDMA capsules in combination with psychological intervention for the treatment of PTSD. While this has been long coming, with the FDA...
